Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 6 studies | 35% ± 15% | |
| Mueller cell | 6 studies | 50% ± 14% | |
| GABAergic neuron | 3 studies | 29% ± 5% | |
| glutamatergic neuron | 3 studies | 42% ± 6% | |
| oligodendrocyte | 3 studies | 23% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 1976.03 | 2640 / 2642 | 100% | 10.49 | 705 / 705 |
| skin | 100% | 1627.54 | 1809 / 1809 | 100% | 8.85 | 471 / 472 |
| kidney | 100% | 1262.58 | 89 / 89 | 100% | 8.87 | 897 / 901 |
| bladder | 100% | 921.38 | 21 / 21 | 99% | 5.70 | 497 / 504 |
| breast | 100% | 908.92 | 458 / 459 | 99% | 6.00 | 1102 / 1118 |
| adrenal gland | 100% | 1945.26 | 258 / 258 | 98% | 6.22 | 226 / 230 |
| uterus | 100% | 712.07 | 170 / 170 | 98% | 5.80 | 451 / 459 |
| liver | 100% | 1021.98 | 225 / 226 | 98% | 5.62 | 399 / 406 |
| thymus | 98% | 737.21 | 643 / 653 | 99% | 5.43 | 601 / 605 |
| prostate | 97% | 642.38 | 237 / 245 | 99% | 4.46 | 496 / 502 |
| intestine | 100% | 917.87 | 964 / 966 | 95% | 4.91 | 500 / 527 |
| stomach | 99% | 768.35 | 356 / 359 | 93% | 4.20 | 266 / 286 |
| ovary | 100% | 820.56 | 180 / 180 | 90% | 3.79 | 389 / 430 |
| esophagus | 100% | 997.47 | 1441 / 1445 | 90% | 3.72 | 165 / 183 |
| lung | 87% | 581.51 | 502 / 578 | 96% | 4.49 | 1106 / 1155 |
| pancreas | 82% | 339.37 | 270 / 328 | 96% | 3.82 | 171 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 6.09 | 29 / 29 |
| spleen | 100% | 922.90 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 6.09 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.80 | 1 / 1 |
| adipose | 100% | 936.47 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1595.13 | 802 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 10.61 | 79 / 80 |
| heart | 98% | 3084.20 | 841 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 570.83 | 1288 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 57% | 560.58 | 532 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070681 | Biological process | glutaminyl-tRNAGln biosynthesis via transamidation |
| GO_0032543 | Biological process | mitochondrial translation |
| GO_0030956 | Cellular component | glutamyl-tRNA(Gln) amidotransferase complex |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0050567 | Molecular function | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | GATB |
| Protein name | Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog) Glutamyl-tRNA amidotransferase subunit B Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome oxidase assembly factor PET112 homolog) (PET112-like) Glutamyl-tRNA amidotransferase subunit B (cDNA FLJ54219, highly similar to Probable glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial) |
| Synonyms | PET112L HSPC199 PET112 |
| Description | FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). . FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln). . |
| Accessions | ENST00000503160.5 D6RDU9 H0Y8G7 ENST00000515812.5 O75879 ENST00000508611.1 D6RGY4 ENST00000511538.5 ENST00000510720.1 H0Y9W6 D6REA0 ENST00000512306.5 B4E0P2 ENST00000515884.5 ENST00000263985.11 H0Y9F2 |
